Wells Fargo & Company Alpha Tau Medical Ltd. Transaction History
Wells Fargo & Company
- $507 Billion
- Q3 2025
A detailed history of Wells Fargo & Company transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 6,000 shares of DRTS stock, worth $22,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000
Previous 2,500
140.0%
Holding current value
$22,260
Previous $7,000
285.71%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DRTS
# of Institutions
37Shares Held
2.25MCall Options Held
0Put Options Held
0-
High Tower Advisors, LLC Chicago, IL687KShares$2.55 Million0.0% of portfolio
-
Hoyle Cohen, LLC269KShares$998,3160.05% of portfolio
-
Levin Capital Strategies, L.P. New York, NY205KShares$759,4880.09% of portfolio
-
Kovitz Investment Group Partners, LLC203KShares$753,9870.0% of portfolio
-
Mariner, LLC Overland Park, KS123KShares$457,2570.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $256M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...